Laurence Greenbaum
Division Director · Emory University School of Medicine
Credentials: · · · · ·
History
- Present
Nephrology Division · Emory University School of Medicine
- 1990–1993
- 1986–1990
Research
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
New England Journal of Medicine · 2013 · 1,219 citations
European Journal of Immunology · 1989 · 291 citations
Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells
The Journal of Immunology · 1988 · First of 6 authors · 224 citations
6 papers
- HT
4 papers
- RE
3 papers
- DG
2 papers
- JK
2 papers
2 papers
2 papers
2 papers
Grants
- 2013–2029
CUREGN 3.0 - Pediatric Nephrology Consortium - PCC
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $7.7M · Research Inst Nationwide Children's Hosp
- 2013–2019
Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers
National Institute of Diabetes and Digestive and Kidney Diseases · UM1
PI · $5.5M · Research Inst Nationwide Children's Hosp
- 1998–2000
Fsgs Permeability Factor in Childhood Nephrotic Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $147.5K · Medical College of Wisconsin
Clinical trials
- 2026–2027
Pilot Study of TTI-0102 in Cystinosis
Principal investigator · Not yet recruiting · Phase 2
Thiogenesis Therapeutics, Inc.
- 2021–2023
Study Evaluating Subjects With Distal Renal Tubular Acidosis
Principal investigator · Terminated · Phase 3
Advicenne Pharma
- 2025–2044
DFT383 in Pediatric Participants With Nephropathic Cystinosis
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
- 2023–2029
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals